{"id":1728,"date":"2025-06-24T19:36:30","date_gmt":"2025-06-24T23:36:30","guid":{"rendered":"https:\/\/www.inflation.us\/news\/?p=1728"},"modified":"2025-06-24T19:36:31","modified_gmt":"2025-06-24T23:36:31","slug":"hims-loses-wegovy-deal-nurs-breaking-out-big","status":"publish","type":"post","link":"https:\/\/www.inflation.us\/news\/articles\/hims-loses-wegovy-deal-nurs-breaking-out-big\/","title":{"rendered":"HIMS Loses WeGovy Deal, NURS Gains by 9.49% to $1.73 Per Share"},"content":{"rendered":"\n<p><span style=\"font-size:14px;\"><span style=\"font-family:Tahoma,Geneva,sans-serif;\"><b>Hims &amp; Hers Health (HIMS) <\/b>has <span style=\"color:#e74c3c;\"><strong>lost<\/strong><\/span> their <strong>Novo<\/strong> deal for <strong>WeGovy<\/strong>.<\/span><\/span><\/p>\n\n<p><span style=\"font-size:14px;\"><span style=\"font-family:Tahoma,Geneva,sans-serif;\">Suddenly, <strong>millions of HIMS customers<\/strong> <strong><span style=\"color:#27ae60;\">need a new<\/span> telehealth provider<\/strong>&nbsp;for their <strong>GLP-1 weight loss drugs<\/strong>.<\/span><\/span><\/p>\n\n<p><span style=\"font-size:14px;\"><span style=\"font-family:Tahoma,Geneva,sans-serif;\">NIA&#39;s <b>Hydreight (TSXV: NURS) <\/b>is about to <strong><span style=\"color:#2980b9;\">capture<\/span> <span style=\"color:#27ae60;\">significant new<\/span> market share<\/strong>!<\/span><\/span><\/p>\n\n<p><span style=\"font-size:14px;\"><span style=\"font-family:Tahoma,Geneva,sans-serif;\"><b>NURS <span style=\"color:#27ae60;\">gained by 9.49%<\/span> <\/b>today to <strong>$1.73 per share<\/strong> and has so far <span style=\"color:#27ae60;\"><strong>gained by 47.86%<\/strong><\/span> since NIA&#39;s suggestion at <strong>$1.17 per share<\/strong>.<\/span><\/span><\/p>\n\n<p><span style=\"font-size:14px;\"><span style=\"font-family:Tahoma,Geneva,sans-serif;\"><b>NURS is <span style=\"color:#27ae60;\">profitable<\/span> with <span style=\"color:#27ae60;\">rapid<\/span> revenue <span style=\"color:#27ae60;\">growth<\/span>!&nbsp;<a href=\"https:\/\/www.inflation.us\/news\/nias-1-telehealth-pick-for-2025-hydreight-technologies-tsxv-nurs\/\">Click here<\/a> to read NIA&#39;s NURS report!<\/b><\/span><\/span><\/p>\n\n<p><span style=\"font-size:14px;\"><span style=\"font-family:Tahoma,Geneva,sans-serif;\"><em>Past performance is not an indicator of future returns. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. NIA has received compensation from&nbsp;NURS&nbsp;of&nbsp;US$30,000 cash for a three-month marketing contract. This message is meant for informational and educational purposes only and does not provide investment advice.<\/em><\/span><\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Hims &amp; Hers Health (HIMS) has lost their Novo deal for WeGovy. Suddenly, millions of HIMS customers need a new telehealth provider&nbsp;for their GLP-1 weight loss drugs. NIA&#39;s Hydreight (TSXV: NURS) is about to capture significant new market share! NURS gained by 9.49% today to $1.73 per share and has so far gained by 47.86% [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1729,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[51,130,10,8],"class_list":["post-1728","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","tag-healthcare","tag-hims","tag-nurs","tag-technology"],"_links":{"self":[{"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/posts\/1728","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/comments?post=1728"}],"version-history":[{"count":1,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/posts\/1728\/revisions"}],"predecessor-version":[{"id":1730,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/posts\/1728\/revisions\/1730"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/media\/1729"}],"wp:attachment":[{"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/media?parent=1728"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/categories?post=1728"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/tags?post=1728"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}